Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Impairment in Glucose Homeostasis Among Obese Adolescents in High Risk Diabetes Prone Population - Jisr Az-Zarqa Village

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2012 by Meir Medical Center
Sponsor:
Information provided by (Responsible Party):
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01535105
First received: February 14, 2012
Last updated: March 13, 2013
Last verified: February 2012

February 14, 2012
March 13, 2013
August 2012
April 2013   (final data collection date for primary outcome measure)
Frequency of Impaired Glucose Homeostasis among obese adolescents in high risk diabetes prone population [ Time Frame: one year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01535105 on ClinicalTrials.gov Archive Site
Description of the metabolic profile in obese adolescents [ Time Frame: One year ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Impairment in Glucose Homeostasis Among Obese Adolescents in High Risk Diabetes Prone Population - Jisr Az-Zarqa Village
Not Provided

Obesity is increasing all over the world in adults, adolescents and children,and is followed by morbidity, including the metabolic syndrome.

Hypothesis: Among obese adolescents there is a subgroup with impaired glucose homeostasis

The aim of the study is to identify adolescents with impaired glucose metabolism, 12-18 years, among high risk diabetes prone population, for diagnosis and treatment.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Subjects of the study will be selected from a primary care clinic

Glucose Metabolism Disorders
Not Provided
Obese Adolescents
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
300
April 2017
April 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinical diagnosis of obesity

Exclusion Criteria:

  • History of disease or drug therapy affecting glucose metabolism
Both
12 Years to 18 Years
No
Contact: Nehama Zuckerman-Levin, MD 972-524354143 zuckerln@netvision.net.il
Israel
 
NCT01535105
Gl homeostasis and obesity
No
Meir Medical Center
Meir Medical Center
Not Provided
Principal Investigator: Nehama Zuckerman-Levin, MD Clalit Health Services
Meir Medical Center
February 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP